Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. - Wikidata - awgldk - TriplyDB

Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.

Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.

http://www.wikidata.org/entity/Q40712583

about

Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells Podocytes Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and Podocytes Molecular mechanisms of renal blood flow autoregulation Pericytes, an overlooked player in vascular pathobiology Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathy.Possible role of transforming growth factor-β1 and vascular endothelial growth factor in Fabry disease nephropathy Deletion of von Hippel-Lindau in glomerular podocytes results in glomerular basement membrane thickening, ectopic subepithelial deposition of collagen {alpha}1{alpha}2{alpha}1(IV), expression of neuroglobin, and proteinuria.Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions.Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria.Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse.The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions.Acute hyperglycemia rapidly stimulates VEGF mRNA translation in the kidney. Role of angiotensin type 2 receptor (AT2).Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus.Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.Glucose and TGFbeta2 modulate the viability of cultured human retinal pericytes and their VEGF release Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy Emerging drugs for diabetic nephropathy.Research into the glomerular podocyte--is it relevant to diabetic nephropathy?Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment.Altered dynamics in the renal lymphatic circulation of type 1 and type 2 diabetic mice Fibrosis: a key feature of Fabry disease with potential therapeutic implications The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability.Essential role of TGF-beta signaling in glucose-induced cell hypertrophy.Reversal of Early Diabetic Nephropathy by Islet Transplantation under the Kidney Capsule in a Rat Model.Podocytes: the Weakest Link in Diabetic Kidney Disease?Diabetes and Kidney Disease: Role of Oxidative Stress.Abnormalities in signaling pathways in diabetic nephropathy.Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.VEGF and podocytes in diabetic nephropathy.Diagnostic biomarkers of diabetic nephropathy.Research progress in signalling pathway in diabetic nephropathy.Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.New and old agents in the management of diabetic nephropathy.Vimentin and laminin are altered on cheek pouch microvessels of streptozotocin-induced diabetic hamsters.In vivo sodium tungstate treatment prevents E-cadherin loss induced by diabetic serum in HK-2 cell line.Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?Effect of retinoic acid in experimental diabetic nephropathy.An endoplasmic reticulum stress-regulated lncRNA hosting a microRNA megacluster induces early features of diabetic nephropathy.

P2860

Q24337548-BB66FF8A-BA6C-49D9-A31D-D3814B517D0B Q26766118-F7FEB103-F21E-493A-B10A-736DA920A965 Q26778527-B1EFC9BF-6870-48D9-B4A6-C332A71E8AE3 Q26825286-279381B9-E689-4807-937D-69B291360CC6 Q28070053-0AAB29AA-34C8-4FF2-A7C1-7CB8B10DA211 Q30501075-4A524CF4-4246-4F84-94D7-05A40A8A7A37 Q33703845-2DFFF2C6-BB7E-45F6-8BD0-32A5E3980750 Q33947170-A3FCAB99-ED6B-475B-867C-C7DA66420426 Q34004047-3DE7EA84-53AF-46AA-BC47-21C2BF7B3596 Q34016067-3D87A8D9-3D5D-4D89-87A5-FB33145A1FD1 Q34024334-0B339442-BCAF-492F-BBCF-B9F36E312FC3 Q34050210-92A42060-527A-4326-8729-B65DC3BD0E9E Q34126751-FEE39B5D-3D17-4A07-9C25-0FAF6D571ED5 Q34239673-AAF4B3F4-0DC0-43E3-80D4-896A462817E9 Q34784085-C2651CB9-1D62-4099-AA8B-350F11C4F83F Q35020672-D2911F2A-C635-44B8-8173-37DABDE0304B Q35649310-1B6DDD7A-8412-4ECA-A57B-0C8CCEE22206 Q35673446-B8A5E88D-CC8F-43B5-A0B8-28E9A317DA4E Q36302838-AAC49275-B1B6-4CFC-A815-D2032D27856A Q36536737-9828AB86-914C-46F3-A728-E95D1CACD861 Q36785571-45F575BE-F1CD-411B-82C5-397A430426C1 Q36868067-07B84C03-3BBE-4994-833C-8DB8E64216DA Q37113004-FD312897-5A35-4051-9DED-3181EEA853BB Q37264349-58A32545-FF5E-4F34-A9DA-22F1D04A6AF3 Q37292388-F5B76C75-4893-4BC6-8EEF-2EB8D592B8B6 Q37306789-42347B4E-9E55-4757-B813-FF9C0AFD7D59 Q37340690-0C724C58-D2FD-438C-BACB-655E0C5BAB2C Q37349206-CDB3DF29-97D5-4340-9EFA-5528155A7D15 Q37708046-19CDE372-2151-4CA6-9E15-6E928EF66DEB Q37959379-79781104-DDA9-4860-9EC8-DF8F2D0D2D8A Q38041671-1FB4886F-8C44-4519-8EE7-61B8BC36283B Q38088843-F45B7B3E-6185-41E9-8C7E-39609AC83FD6 Q38217707-C18CA8EF-E60F-4821-89A0-7798CD6E56E1 Q38317272-E6B1E3BE-DE92-4028-85EB-E6DAEA2BB442 Q38738871-FB6B6361-37A1-41E9-8C87-65F7E3351372 Q38862865-35286922-8468-4CE6-8766-3F061F6FDA75 Q38904867-A44ADBB1-F215-43BE-8755-FE6F855C5A05 Q38942962-0D0B53D0-8A9B-468A-9A48-842A22FE52AC Q40490436-AFF18B48-C989-469E-8E28-3C7E89A08B15 Q40560353-CF757F7F-D506-4AEF-9557-6DAFE52AD2B9

P2860

Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.

http://www.wikidata.org/entity/Q40712583

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Effects of high glucose and TG ...... wth factor in mouse podocytes.

@en

type

label

Effects of high glucose and TG ...... wth factor in mouse podocytes.

@en

prefLabel

Effects of high glucose and TG ...... wth factor in mouse podocytes.

@en

P1433

Q40712583-70E7C2B5-4082-4D1B-BF48-B0A31BAEEC61

P1476

Q40712583-03BC80B1-E273-4033-99DD-B9548E4D96DD

P2093

Q40712583-6CD100FA-68EB-4F8A-BB5F-8B939FF8CA32

Q40712583-78570A83-D6FA-4811-BE69-9F9D73DF164C

Q40712583-7FC3944C-6972-4F2F-B3B3-A11417FF74CE

Q40712583-E09D5537-D162-4E0C-B900-C953FF5D33BD

Q40712583-E939907B-9E0E-41C6-82AC-7E386A72FC15

Q40712583-F51AFDA7-5279-4F9B-9475-4FB6019DB9E2

Q40712583-FE5FD055-B9A2-435D-A023-35C5A270F3A5

P2888

Q40712583-534A5D69-0DD2-40EA-A5A3-F1414C3997C3

P304

Q40712583-78396242-3797-4B78-A92E-1DD724C4F372

P31

Q40712583-60CFBD04-1980-4CE6-A100-C532F2F9A056

P356

Q40712583-A8131C28-610B-442D-A355-A03442A80EEF

P407

Q40712583-A69CECD3-6896-4BF6-941A-D2AE9719D888

P433

Q40712583-4B8902C6-934B-4D90-AC10-9F2270BC03C3

P478

Q40712583-23274A26-AB1B-444F-9443-36AE169B0849

P50

Q40712583-E7B2013A-A842-43D7-A4F2-5B42A899E369

P577

Q40712583-B748D379-497A-4ED8-800E-5A78A3C06DF5

P5875

Q40712583-188AD523-AFD2-405A-A3FD-0A9633DA0F06

P6179

Q40712583-24E5B7CA-4DB6-4E0B-A141-6A0674A46EE2

P698

Q40712583-2D3DF7CA-00CC-43BB-B122-340AD4C9AF91

P921

Q40712583-4505A118-0F7F-4579-814C-87B2391C190B

P356

J.1523-1755.2002.00528.X

P1433

Kidney International

P1476

Effects of high glucose and TG ...... wth factor in mouse podocytes.

@en

P2093

Dong Cheol Han

http://www.w3.org/2001/XMLSchema#string

Fuad N Ziyadeh

http://www.w3.org/2001/XMLSchema#string

M Carmen Iglesias-de la Cruz

http://www.w3.org/2001/XMLSchema#string

Martine Kouahou

http://www.w3.org/2001/XMLSchema#string

Motohide Isono

http://www.w3.org/2001/XMLSchema#string

Peter Mundel

http://www.w3.org/2001/XMLSchema#string

Sheldon Chen

http://www.w3.org/2001/XMLSchema#string

P2888

j.1523-1755.2002.00528.x

P304

901-913

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1523-1755.2002.00528.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11221714

http://www.w3.org/2001/XMLSchema#string

P6179

1033635253

http://www.w3.org/2001/XMLSchema#string

P698

12164872

http://www.w3.org/2001/XMLSchema#string

P921